Alendronate Effervescent Oral Tablet

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 35/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Erosive Osteoarthritis

Conditions

Erosive Osteoarthritis

Trial Timeline

Nov 13, 2019 → Mar 9, 2022

NCT ID

NCT04403698

About Alendronate Effervescent Oral Tablet

Alendronate Effervescent Oral Tablet is a phase 2 stage product being developed by Amgen for Erosive Osteoarthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT04403698. Target conditions include Erosive Osteoarthritis.

What happened to similar drugs?

6 of 13 similar drugs in Erosive Osteoarthritis were approved

Approved (6) Terminated (0) Active (7)

✅Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved

✅Esomeprazole + LansoprazoleAstraZenecaApproved

✅Esomeprazole + EsomeprazoleAstraZenecaApproved

✅esomeprazole magnesium (oral medication)AstraZenecaApproved

✅Omeprazole/sodium bicarbonateBausch HealthApproved

🔄E3810 + E3810 + PlaceboEisaiPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04403698	Phase 2	Completed	Nov 13, 2019	Mar 9, 2022	Erosive Osteoarthritis

Competing Products

20 competing products in Erosive Osteoarthritis

See all competitors

Product	Company	Stage	Hype Score
YH1885L(Revaprazan) + Esomeprazole 20mg + placebo	Yuhan	Phase 2	35
E3810 + E3810 + Placebo	Eisai	Phase 3	40
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUM	Eisai	Phase 3	40
Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenone	Eisai	Approved	43
ABT-981 + Placebo for ABT-981	AbbVie	Phase 2	35
Omeprazole	AstraZeneca	Phase 3	40
Esomeprazole + Lansoprazole	AstraZeneca	Approved	43
Nexium 20mg + Nexium 10mg	AstraZeneca	Phase 3	47
Omeprazole	AstraZeneca	Phase 3	40
AZD0865	AstraZeneca	Phase 2	35
Esomeprazole + Lansoprazole	AstraZeneca	Approved	43
Esomeprazole + Esomeprazole	AstraZeneca	Approved	43
AZD0865	AstraZeneca	Phase 2	35
esomeprazole magnesium (oral medication)	AstraZeneca	Approved	43
Omeprazole/sodium bicarbonate	Bausch Health	Approved	37
Vonoprazan	Phathom Pharmaceuticals	Phase 1	23
Vonoprazan + Lansoprazole	Phathom Pharmaceuticals	Phase 3	34
Vonoprazan + Placebo	Phathom Pharmaceuticals	Phase 2	29
Vonoprazan	Phathom Pharmaceuticals	Pre-clinical	27
Vonoprazan + Placebo	Phathom Pharmaceuticals	Phase 3	34